Td Private Client Wealth LLC Bio N Tech Se Transaction History
Td Private Client Wealth LLC
- $3.18 Trillion
- Q2 2024
A detailed history of Td Private Client Wealth LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Td Private Client Wealth LLC holds 927 shares of BNTX stock, worth $107,179. This represents 0.0% of its overall portfolio holdings.
Number of Shares
927Holding current value
$107,179% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$957 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$554 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$506 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$338 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$219 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...